Reflow Medical Receives Approval in Japan for the Wingman Catheter to Cross Chronic Total Occlusions (CTOs) in Peripheral Artery Disease

Reflow Medical, Inc., a California-based medical device company, announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has approved the Wingman™ CTO Catheter. Reflow Medical has partnered with Century Medical, Inc. (CMI), a leading medical device distributor based in Tokyo, to introduce the Wingman CTO Catheter in Japan.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201008005741/en/

Wingman CTO Catheter (Photo: Business Wire)

The Wingman Catheter crosses peripheral CTOs using an extendable beveled tip. The physician controls the advancement and activation of the tip to create a channel to help penetrate, or cross, the occlusion with a guidewire, enabling further treatment of the lesion with therapeutic devices. The catheter is compatible with the physician’s preferred guidewire and procedural technique.

Approval by Japan’s PMDA follows the completion of the Wing-IT CTO clinical trial, a prospective, international, multicenter study that treated 85 patients and followed them for 30 days. The

Read More

Nationwide genomic analysis to study possible reasons for the low COVID-19 mortality rate in Japan

TOKYO, Sept. 29, 2020 /PRNewswire/ — Japanese researchers have launched the Joint Research Coronavirus Task Force to gather genetic information for predicting severe cases of COVID-19 and developing effective vaccines. 

National Network of Medical Institutions © Keio University
National Network of Medical Institutions © Keio University

The Keio Research Highlights website offers more details about this and other recent research being conducted by researchers at Keio University.

https://research-highlights.keio.ac.jp/

On 21 May, 2020, the Joint Research Coronavirus Task Force was launched in Japan to promote the development of a mucosal vaccine for COVID-19 based on advanced genomic analysis.

“We will analyze 600 blood samples taken from Japanese COVID-19 patients located in approximately 100 hospitals throughout Japan,” explains Takanori Kanai of the Keio University School of Medicine, who leads the task force. “One of the goals of the research is to try to understand why the mortality rate due to COVID-19 has remained significantly lower in

Read More

Laughing the best medicine to avoid higher nursing care risks: Japan researchers

This image shows a smiling couple. (Getty)

Kenji Takeuchi, an associate professor at Nagoya University Graduate School of Medicine who conducted research on the relationship between laughter and nursing care risks, is shown in this photo provided by him.


TOKYO — The effect a chuckle has on an individual’s physical and mental health has been scientifically examined from various angles and one central Japan study has found that the absence of laughter can lead to serious nursing care risks for the elderly.


A research team at Nagoya University studied the differences in the potential likelihood of requiring nursing care between individuals who laugh regularly and those who do not giggle as much. The unprecedented, large-scale research examined some 14,000 people over a span of three years.


The research team was led by Kenji

Read More